Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Pharmacology|February 16, 2019
The effect of exenatide (a GLP-1 analog) and sitagliptin (a DPP-4 inhibitor) on plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and concentration in normal and fructose-fed ratsGrażyna Wójcicka, Mariusz Zaręba, Anna Warpas, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|August 9, 2016
Synthesis, antibacterial and antiproliferative potential of some new 1-pyridinecarbonyl-4-substituted thiosemicarbazide derivativesMonika Pitucha, Maciej Woś, Malgorzata Miazga-Karska, et al.
Bioorganic Chemistry|April 13, 2020
1,2,4-Triazolin-5-thione derivatives with anticancer activity as CK1γ kinase inhibitorsMonika Pitucha, Monika Janeczko, Katarzyna Klimek, et al.
International Journal of Molecular Sciences|July 2, 2021
Cytotoxic Activity against A549 Human Lung Cancer Cells and ADMET Analysis of New Pyrazole DerivativesAgnieszka Czylkowska, Małgorzata Szczesio, Anita Raducka, et al.
International Journal of Molecular Sciences|August 26, 2022
New Derivatives of 5-((1-Methyl-Pyrrol-2-yl) Methyl)-4-(Naphthalen-1-yl)-1,2,4-Triazoline-3-Thione and Its Coordination Compounds with Anticancer ActivityAgnieszka Czylkowska, Suneel Lanka, Małgorzata Szczesio, et al.
Molecules (Basel, Switzerland)|September 6, 2018
Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D₂ Receptor LigandMagda Kondej, Agata Bartyzel, Monika Pitucha, et al.
Bioorganic Chemistry|April 15, 2022
Polymer microspheres modified with pyrazole derivatives as potential agents in anticancer therapy - Preliminary studiesBeata Podkościelna, Katarzyna Klimek, Zbigniew Karczmarzyk, et al.
Pharmacological Reports : PR|January 22, 2022
Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modificationsJustyna Żuk, Damian Bartuzi, Andrea G Silva, et al.
Toxicology and Applied Pharmacology|July 23, 2023
Novel phenoxyacetylthiosemicarbazide derivatives as novel ligands in cancer diseasesPaweł Kozyra, Grzegorz Adamczuk, Zbigniew Karczmarzyk, et al.
Molecules (Basel, Switzerland)|January 11, 2025
Thiosemicarbazone-Based Compounds: A Promising Scaffold for Developing Antibacterial, Antioxidant, and Anticancer TherapeuticsAgnieszka Czylkowska, Monika Pitucha, Anita Raducka, et al.
Pageof 8